Nipt test: il test del DNA fetale
The NIPT test (acronym for ‘Non-Invasive Prenatal Testing’), commonly known as foetal DNA test, is a reliable and accurate prenatal screening test that allows to predict with a high degree of reliability the risk for the foetus of presenting chromosomal abnormalities such as Down Syndrome, Edwards Syndrome, Patau Syndrome, Trisomy of the X chromosome, Klinefelter Syndrome, Turner Syndrome, etc.
Unlike other diagnostic techniques, such as amniocentesis and villocentesis, the NIPT test is a non-invasive test, it does not involve any risk for the pregnant woman and the child: it is enough to take a blood sample from the woman from the tenth gestational week onwards.
The DNA test analyses the fragments of foetal DNA that circulate freely in the maternal blood allowing to obtain an accurate overview of the chromosomal status of the foetus that can have a great impact on their future health.
The NIPT test is a clinically validated screening test on thousands of pregnancies that detects aneuploidies 21, 18, 13 and all other chromosomes, sexual aneuploidies, microdeletions, partial duplications and the sex of the foetus.
The CSM offers free post-test advice from one of our geneticists to clarify the meaning, limits, reliability and specificity of the test performed in order to correctly interpret the results obtained.
Book your test!
Find the centre nearest to you
Latest-generation laboratory tests with a certified quality system.